Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: A meta-analysis - 06/09/22
Doi : 10.1016/j.jinf.2022.06.027
Mingyang Yang a, b, 1, Toni Li c, 1, Yushu Wang d, 1, Carolyn Tran e, Siyi Zhao f, Guangyu Ao g, ⁎ 
a West China Fourth Hospital/West China School of Public Health, Sichuan University, Chengdu, Sichuan, China
b Health Emergency Management Research Center, China-PUMC C.C. Chen Institute of Health, Sichuan University, Chengdu, Sichuan, China
c School of Medicine, Queen's University, Kingston, Canada
d Chengdu West China Clinical Research Center, Chengdu, Sichuan, China
e Schulich School of Medicine and Dentistry, Western University, London, Canada
f Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China
g Department of Nephrology, Chengdu First People's Hospital, Chengdu, Sichuan, China
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Included studies compared the effect of monoclonal antibody therapy on clinical outcomes of organ transplant recipients with COVID-19. |
• | A total of 8 articles comprising 930 organ transplant recipients with COVID-19 were included in the analysis. |
• | Monoclonal antibody therapy significantly improve both severity and mortality among organ transplant recipients with COVID-19. |
Keywords : COVID-19, Monoclonal antibody, Transplant recipient
© 2022
Publié par Elsevier Masson SAS.
Vol 85 - N° 4
P. 436-480 - octobre 2022 Retour au numéro
Article précédent
- Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men
- Angelo Roberto Raccagni, Davide Mileto, Diana Canetti, Andrea Marco Tamburini, Alberto Rizzo, Elena Bruzzesi, Antonella Castagna, Silvia Nozza
- Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: An Italian cohort study
- Carlotta Sacerdote, Lorenzo Milani, Anna Castiglione, Eva Pagano, Enrica Migliore, Carlo Albera, Mario Bo, Luca Brazzi, Francesco Giuseppe De Rosa, Marilena Durazzo, Enrico Lupia, Giuseppe Montrucchio, Emanuele Pivetta, Massimo Porta, Luca Scaglione, Franco Veglio, Marinella Zanierato, Fulvio Ricceri, Valeria Caramello, Gitana Scozzari, Antonio Scarmozzino, Giovannino Ciccone & COVID-EASYNET working group, Grazia Maria Auzzas, Cristina Balestro, Carol Brentisci, Francesco Brunetti, Umberto Fiandra, Claudia Galassi, Manuela Gangemi, Lisa Giacometti, Marco Gilardetti, Fulvio Lazzarato, Vitor Hugo Martins, Matteo Papurello, Francesca Ponti di Sant’Angelo, Stefano Roggero, Fabio Saccona, Carlo Silvestre, Antonella Stura, Danila Turco, Federico Vischia, Susanna Zozzoli
Bienvenue sur EM-consulte, la référence des professionnels de santé.